Researches

Displaying 311 - 320 of 3943
# Title Department Research Year
311 Microwave-Assisted Synthesis, Biological Activity Evaluation, Molecular Docking, and ADMET Studies of Some Novel Pyrrolo [2,3-b] Pyrrole Derivatives Department of Medicinal Chemistry 2022
312 mRNA-loaded lipid nanoparticles targeting immune cells in the spleen for use as cancer vaccines Department of Pharmaceutics 2022
313 Nanocomposite of gold nanoparticles@nickel disulfide-plant derived carbon for molecularly imprinted electrochemical determination of favipiravir Department of Pharmaceutical Analytical Chemistry 2022
314 New 1, 2, 4‐oxadiazole/pyrrolidine hybrids as topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity Department of Pharmaceutical Organic Chemistry 2022
315 New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase Department of Pharmaceutical Organic Chemistry 2022
316 New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization Department of Pharmaceutical Organic Chemistry 2022
317 New 1,2,4-oxadiazole/pyrrolidine hybrids as Topoisomerase IV and DNA gyrase inhibitors with promising antibacterial activity 2022
318 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
319 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
320 New Insights into the Structural Requirements of Isatin-Derived Pro-Apoptotic Agents against Acute Myeloid Leukemia Department of Medicinal Chemistry 2022